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Abstract
The early events that initiate inflammation in the adipose tissue during obesity are not well defined. It is unclear whether
the recruitment of CD8 T cells to the adipose tissue during onset of obesity occurs through antigen-dependent or -
independent processes. We have previously shown that interaction between NKG2D (natural-killer group 2, member D) and
its ligand Rae-1e is sufficient to recruit cytotoxic T lymphocytes to the pancreas and induce insulitis. Here, we tested
whether NKG2D–NKG2D ligand interaction is also involved in obesity-induced adipose tissue inflammation and insulin
resistance. We observed a significant induction of NKG2D ligand expression in the adipose tissue of obese mice, especially
during the early stages of obesity. However, mice lacking NKG2D developed similar levels of insulin resistance and adipose
tissue inflammation compared to control mice when placed on a high-fat diet. Moreover, overexpression of Rae-1e in the
adipose tissue did not increase immune cell infiltration to the adipose tissue either in the setting of a normal or high-fat
diet. These results indicate that, unlike in the pancreas, NKG2D–NKG2D ligand interaction does not play a critical role in
obesity-induced inflammation in the adipose tissue.
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Introduction
Recent studies have pointed to chronic inflammation in insulin
target tissues, such as muscle, liver, and adipose tissue, as one of
the causal links between obesity and insulin resistance [1–3].
Multiple inflammatory cytokines (TNF-a, IL-6, etc.) and signaling
pathways (JNK, NF-kB) have been implicated in obesity-induced
insulin resistance [4–10].
The adipose tissue plays a key role in regulating systemic
metabolism. In addition to being a storage depot for lipids, the
adipose tissue secretes a number of paracrine and endocrine
factors, known as adipocytokines, that modulate metabolism and
inflammation in liver, muscle, and pancreatic islets [11]. In obese
mice, the secretion profile of the adipose tissue is altered by the
pro-inflammatory milieu. Secretion of pro-inflammatory adipocy-
tokines, such as resistin, IL-6, and TNF-a is increased while anti-
inflammatory and insulin-sensitizing adipocytokines like adipo-
nectin are down-regulated. It is therefore thought that dysregu-
lation of the adipose tissue during obesity induces insulin-
resistance and inflammation in major metabolic tissues.
Despite much effort, the initiating events that cause inflamma-
tion in obese adipose tissue are yet to be clearly understood.
Hypoxia and ER stress have been shown to activate inflammatory
signaling pathways in obese adipose tissue, but it is unclear
whether they are the primary switch that triggers inflammation
[12–16].
Various immune cell types have been implicated in obesity-
induced insulin resistance [17]. Among them, macrophages are
considered to be the major mediators of adipose tissue inflamma-
tion [18,19]. Macrophages can constitute up to ,40% of the cell
number in the adipose tissue during obesity and are responsible for
the majority of Tnfa expression in the adipose tissue [20,21].
Additionally, in contrast to the resident macrophages found in the
adipose tissue of lean mice, the macrophages recruited to the
adipose tissue during obesity are pro-inflammatory [22]. The
resident macrophages display characteristics of ‘‘alternatively
activated’’ or M2 macrophages and express anti-inflammatory
cytokines such as IL-10, while the newly infiltrating macrophages
are of the ‘‘classically activated’’ or M1 category and express high
levels of TNF-a and iNOS [22,23].
More recently, T cells have emerged as a key component in
obesity-induced adipose tissue inflammation. Multiple studies have
reported increased numbers of CD8 T cells in the adipose tissue of
obese rodents and humans along with elevated levels of IFN-c and
RANTES, which are important for T cell function and
recruitment [24–29]. Interestingly, accumulation of T cells occurs
prior to macrophage infiltration and onset of insulin resistance,
and depletion of CD8 T cells alleviates adipose tissue inflamma-
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tion and insulin resistance in obese mice [26,28,30–32]. This
suggests that recruitment of pro-inflammatory T cells could be a
primary event that initiates adipose tissue inflammation.
Still, the question of what initiates the infiltration and activation
of CD8 T cells in the adipose tissue remains to be answered. It has
been suggested that T cells are responding to chemokines and
cytokines produced in the adipose tissue in response to cell death
or hypoxia [25,33,34]. A more provocative idea is that certain
antigens produced in the adipose tissue under obese conditions
could direct immune cell responses. This hypothesis is supported
by the observation that adipose tissue T cells express a restricted
repertoire of T cell receptors (TCRs), whose profile is unique from
that of T cells in the spleen or lymph nodes [31–33].
An alternative way of T cell recruitment and accumulation in
tissues is through the interaction between certain high affinity
receptors and their ligands independent of antigen. Our lab has
previously shown that NKG2D (natural-killer group 2, member
D), a cell surface receptor expressed in cytotoxic T lymphocytes
(CTLs), is sufficient to induce recruitment of CTLs to pancreatic
islets over-expressing its ligand and cause insulitis [35]. NKG2D
binds to a number of distinct ligands which are not expressed in
normal adult tissues, but up-regulated in response to stress
conditions, such as oxidative stress and viral infection [36]. During
obesity, the adipose tissue is subjected to various types of stresses,
such as nutrient stress (from elevated glucose and lipid levels), ER
stress, oxidative stress, hypoxia, and chronic inflammation [37,38].
In this study, we examined whether NKG2D ligand expression is
induced in the adipose tissue during obesity. We also tested
whether interaction between NKG2D and its cognate ligands




3T3-L1 fibroblasts (from American Tissue Type Culture
Collection) were maintained and differentiated as previously
described [39]. For NKG2D ligand expression experiments,
differentiated 3T3-L1 cells (day 7, ,95% differentiated) were
treated with 5 mg/ml insulin (Sigma-Aldrich, St. Louis, MO),
50 ng/ml TNF-a (Peprotech, Rocky Hill, NJ), 3 mg/ml tunica-
mycin (EMD Millipore, Darmstadt, Germany), 50 mU/ml glucose
oxidase (Sigma-Aldrich), 100 ng/ml LPS (Invivogen, San Diego,
CA), and 500 mM palmitate (Nu-Chek Prep, Elysian, MN)
conjugated to 250 mM fatty acid-free BSA (SeraCare Life
Sciences, Milford, MA) for 24 h.
Mice
All mice were housed in a specific pathogen-free facility at
Washington University School of Medicine. C57BL/6J and ob/ob
(B6.V-Lepob/J) mice were purchased from The Jackson Labora-
tory (Bar Harbor, ME). NKG2D-deficient (Klrk1-/-) mice have
been previously described [40]. The PCCALL-Rae1e mice have
been previously described [35]. Adiponectin-Cre transgenic mice
were provided by Dr. P. Scherer (University of Texas Southwest-
ern Medical Center) [41]. High-fat diet (HFD) mice were fed the
D12492 60 kcal% fat diet (20 kcal% protein, 20 kcal%
carbohydrate. Each gram contains 5.24 kcal, including 228 mg
cholesterol from lard) from Research Diets, Inc. (New Brunswick,
NJ) for up to 18 weeks. Normal chow control mice were fed a diet
of 13 kcal% fat (25 kcal% protein, 62 kcal% carbohydrate. Each
gram contains 3.07 kcal) from LabDiet (St. Louis, MO). Care and
use of mice were conducted in accordance with protocols
approved by the Animal Studies Committee at Washington
University in St. Louis (Protocol Number: 20120013), in
compliance with the Animal Welfare Act.
Real-time Quantitative PCR Analysis
RNA was extracted from 3T3-L1 cells, epidydymal fat tissue, or
fractionated adipocytes and stromal vascular cells with TRIzol
(Life Technologies, Grand Island, NY). RNA was reverse-
transcribed using random primers with the High Capacity cDNA
Reverse Transcription Kit (Life Technologies). Real-time quanti-
tative PCR was performed using the SYBR Green method on the
7500 Fast Real-Time PCR system (Life Technologies). Transcript
levels were normalized to HPRT or b-actin.
The sequence of primers were: Rae-1 pan F - CCA CCT GGG
AAT TCA ACA TC; Rae-1 pan R - TGA TCT TGG CTT TTC
CTT GG; Mult-1 F - CAA AGG TCT GCT GCT TCA CA;
Mult-1 R - TGC TTG TGT CAA CAC GGA AT; H60b F -
TGC CTC AAC AAA TCG TCA TC; H60b R - CAC TCA
GAC CCT GGT TGT CA; CD68 F - TAC CCA ATT CAG
GGT GGA AG; CD68 R - ATG GGT ACC GTC ACA ACC
TC; TNF-a F - ACG GCA TGG ATC TCA AAG AC, TNF-a R
- AGA TAG CAA ATC GGC TGA CG; MCP-1 F - TCC CAA
TGA GTA GGC TGG AG; MCP-1 R - TCT GGA CCC ATT
CCT TCT TG; adiponectin F - GAC AAG GCC GTT CTC
TTC AC; adiponectin R - CAG ACT TGG TCT CCC ACC TC;
adipsin F - AGC GAT GGT ATG ATG TGC AG; adipsin R -
ATT GCA AGG GTA GGG GTC TC; b-actin F - GAA GAG
CTA TGA GCT GCC TGA; b-actin R - GCA CTG TGT TGG
CAT AGA GGT, HPRT F - ATC AGT CAA CGG GGG ACA
TA; HPRT R - AGA GGT CCT TTT CAC CAG CA.
Fat Tissue Fractionation
The epidydymal fat tissue was isolated from euthanized mice,
rinsed in PBS, weighed, and minced into small pieces (,1 mm).
The minced tissue was digested in KRH buffer (4.8 mM KCl,
2.5 mM CaCl2, 1.2 mM MgSO4, 118 mM NaCl, 20 mM HEPES
[pH 7.5]) supplemented with 1.5% bovine serum albumin (BSA)
(SeraCare Life Sciences), 30 mg/ml Liberase (Roche Applied
Science, Indianapolis, IN), and 1 mg/ml DNaseI (Sigma-Aldrich)
at 37uC for 25,40 minutes with vigorous shaking. The digested
samples were strained through a sterile 250 mm nylon mesh (Sefar,
Buffalo, NY) and centrifuged at 200 g for 10 min. The floating
cells were collected as the adipocyte fraction and the pelleted cells
were collected as the stromal vascular fraction (SVF). The
adipocytes were washed twice with KRH buffer +1.5% BSA
before being processed for RNA extraction. The SVF was
resuspended in ACK lysis buffer (150 mM NH4Cl, 10 mM
KHCO3, 0.1 mM EDTA) and incubated at room temperature
for 2 minutes to deplete erythrocytes, washed twice with KRH
buffer +1.5% BSA, and finally resuspended in FACS buffer (1%
BSA, 2 mM EDTA in 16PBS) for flow cytometry or processed for
RNA extraction.
Isolation of Splenocytes and Peripheral Blood
Mononuclear Cells (PBMCs)
Spleen harvested from euthanized mice were homogenized and
filtered through a 40-micron cell strainer. The cells were then
washed with PBS, depleted of erythrocytes with ACK lysis buffer,
washed twice with PBS, and resuspended in FACS buffer.
For PBMCs, whole blood was collected from mice in EDTA-
coated vacutainers (BD Biosciences, San Jose, CA). The blood was
mixed with PBS and centrifuged at 300 g for 10 min. The cells
were then resuspended in ACK lysis buffer, washed twice with
PBS, and resuspended in FACS buffer.
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Immunofluorescent Staining and Flow Cytometry
Single-cell suspensions from the SVF of fat tissue, spleen, and
blood samples were incubated in FcBlock (BD Biosciences) for
15 min at 4uC. The cells were then stained with fluorophore-
conjugated antibodies for 20 min at 4uC in the dark. The
antibodies were purchased from BD Biosciences (CD8-FITC,
CD11c-FITC, NK1.1-FITC, CD4-PE/Cy7, CD45.2-APC),
eBioscience (San Diego, CA) (NKG2D-PE, F4/80-PE/Cy7,
CD11b-APC/eFluor780), or BioLegend (San Diego, CA)
(CD3e-Pacific Blue). Dead cells were excluded with 7-AAD
staining (BD Biosciences). Flow cytometry data was acquired with
FACSCantoII or LSRII flow cytometer (BD Biosciences) and
analyzed with FlowJo (Treestar, Ashland, OR).
Metabolic Studies
Male mice were placed on a HFD beginning at 8 weeks of age,
and body weight was monitored weekly. Mice were fasted
overnight (12 h) prior to measuring fasting blood glucose or
performing glucose tolerance tests (GTT) and insulin tolerance
tests (ITT). For GTT, glucose (1 g/kg in saline) was administered
by intraperitoneal (i.p.) injection. Blood glucose levels were
measured before and 15, 30, 60, 120 min after glucose injection
with a handheld ContourTS glucometer (Bayer, Tarrytown, NY).
For ITT, insulin (0.75 U/kg, Humulin R, Lilly, Indianapolis, IN)
was administered by i.p. injection and blood glucose levels were
measured before and 15, 30, 60, 120 min after insulin injection.
CTL Adoptive Transfer
CTL adoptive transfer experiments were performed as
described previously [35]. Briefly, CTLs were generated in vitro
by culturing splenocytes and lymph node cells from OT-1 T cell
receptor transgenic mice in IMDM + 10% FCS with 1 mM OVA
peptide (SIINFEKL) (provided by Dr. P. Allen, Washington
University School of Medicine) for 5 days. Live cells were
harvested using Ficoll-hypaque (GE Healthcare, Piscataway, NJ)
and labeled with 1 mM CFSE (Invitrogen) and injected intrave-
nously (107 cells/mouse). Epididymal adipose tissue and spleen
were harvested 24 h after injection and processed for flow
cytometry.
Figure 1. Insulin and TNF-a increases NKG2D ligand expression in 3T3-L1 adipocytes. (A-C) Differentiated 3T3-L1 cells were treated with
insulin (0.5–5 mg/ml) or TNF-a (10–100 ng/ml) for 24 hours. The cells were then analyzed by quantitative PCR to determine the expression levels of
(A) Rae-1, (B) Mult-1, and (C) H60b. (D) Differentiated 3T3-L1 cells were treated with insulin, TNF-a, tunicamycin, glucose oxidase, LPS, and palmitate.
The cells were then analyzed by quantitative PCR for NKG2D ligand expression. The results were normalized to HPRT levels and are shown as fold-
increase over control. The data represent mean 6 SD of 3 independent experiments. * p,0.05, ** p,0.01 vs. control.
doi:10.1371/journal.pone.0110108.g001
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Statistical analyses
Data were routinely presented as mean +/- standard deviation
(SD), and we determined significance by the Student’s t test or
ANOVA. We considered a P value of ,0.05 as statistically
significant.
Results
Induction of NKG2D ligands in fat tissue of obese mice
NKG2D binds to a number of distinct ligands, which are
usually not expressed in normal adult tissues, but are up-regulated
in response to various ‘cellular stress conditions’, such as oxidative
stress, viral infection, and DNA damage [42]. The induced ligands
are thought to act as a signal to the immune system for the
removal of damaged cells. In order to identify factors that could
potentially regulate NKG2D ligands in adipocytes, we incubated
differentiated 3T3-L1 cells with factors that induce various cell
responses. Insulin and TNF-a treatment caused a significant
increase in the mRNA levels of different NKG2D ligands at
varying concentrations. Insulin had the greatest effect on Rae-1
mRNA level among the NKG2D ligands (Fig. 1A) while TNF-a
treatment increased both Rae-1 and Mult-1 (Fig. 1A and B). H60b
mRNA levels were only moderately affected by insulin and TNF-a
(Fig. 1C). Meanwhile, incubation in tunicamycin, glucose oxidase,
LPS, and palmitate did not have an effect (Fig. 1D).
Insulin and TNF-a levels are known to be elevated during
obesity in humans and rodents. To address whether NKG2D
ligands are induced by obesity, we analyzed the adipose tissue of
diet-induced obese (DIO) mice. RNA was isolated from epidid-
ymal adipose tissue obtained from mice fed either a normal diet
(ND) or a high-fat diet (HFD) and analyzed by real-time qPCR.
Rae-1 and Mult-1 mRNA levels were increased approximately 5-
fold and 17-fold respectively in the DIO-mice compared to lean
control mice. (Fig. 2A). H60b expression level was not altered in
DIO-mice. As control, we confirmed increased expression of
CD68, TNF-a, and MCP-1 and decreased expression of
adiponectin and adipsin in DIO-mice (Fig. 2B).
To confirm these results, we also analyzed the adipose tissue of
ob/ob mice, a genetic model of obesity (Fig. 2C, D). Similar to the
DIO-mice, Rae-1 and Mult-1 transcript levels were increased in
the ob/ob mice compared to lean ob/+ controls (Fig. 2C). In
addition, H60b mRNA level was also slightly increased in the ob/
ob mice (Fig. 2C).
The adipose tissue is composed of adipocytes, immune cells,
vascular cells, and undifferentiated preadipocytes. In order to
determine which cell types express NKG2D ligands, the
epidydymal adipose tissue of DIO-mice was fractionated into
adipocytes and the stromal vascular fraction (SVF) via collagenase
digestion. Rae-1 was expressed predominantly in the adipocyte
fraction, while Mult-1 had similar expression levels in the
adipocytes and the SVF (Fig. 2E). H60b expression was higher
in the adipocyte fraction (Fig. 2E).
Induction of NKG2D ligands in the adipose tissue of obese mice
led us to hypothesize that this could be a mechanism by which
CD8 T cells are recruited to the adipose tissue to initiate
inflammation during obesity. Infiltration of CD8 T cells to the
adipose tissue of DIO-mice has been shown to occur relatively
soon after starting the HFD regimen (4,5 weeks after initiation of
diet). In order to see whether NKG2D ligand induction occurs
within a similar time frame, we measured the time-course kinetics
of NKG2D ligand expression in DIO-mice (Fig. 2F). The mRNA
levels of Rae-1 and Mult-1 were highest at the earliest time-point
measured (3 weeks post-initiation of diet) and gradually decreased
during the progression of obesity. These results suggest that early
changes that occur in the adipose tissue of mice on a HFD induce
the expression of NKG2D ligands.
Obesity-induced insulin resistance and adipose tissue
inflammation in NKG2D-deficient mice. The NKG2D–
deficient (klrk-/-) mice lack the expression of NKG2D in all
immune cells including CD8 T cells. To directly test whether
NKG2D ligands are involved in the development of obesity-
induced insulin resistance, we placed wild-type and klrk-/- mice on
a HFD. Age-matched male mice were divided into two groups and
placed on either ND or HFD. We measured the changes in body
weight and fasting glucose levels for 18 weeks. In order to measure
insulin sensitivity, we performed glucose tolerance test (GTT) and
insulin tolerance test (ITT) at 6, 12, and 18 weeks after starting the
diet regimen.
At baseline (8-weeks old), there was no difference between WT
and klrk-/- mice in body weight (Fig. 3A) and fasting blood glucose
levels (Fig. 3B). Rapidly within a few weeks, mice on the HFD
began to outweigh mice on the normal diet, and the gap between
the two groups continued to grow until the end of the experiment.
There was no difference in body weight change between WT and
klrk-/- mice in either the ND or HFD group throughout the
experiment.
In GTT experiments (Fig. 3C), obese mice were significantly
less tolerant compared to lean mice in both WT and klrk-/- mice.
However, there was no difference between WT and klrk-/- mice in
any of the time points. Similar results were obtained in ITT assays
(Fig. 3D) with WT and klrk-/- mice displaying similar degrees of
insulin sensitivity. Fasting glucose, which is also indicative of
insulin sensitivity, was not altered in klrk-/- mice. (Fig. 3B)
At the end of 18 weeks on the diet regimen, the epididymal
adipose tissue was harvested to analyze immune cell infiltration.
The SVF was isolated by collagenase digestion, stained for cell
surface markers, and analyzed by flow cytometry. Consistent with
previous reports, there was a significant increase in the number of
F4/80+CD11c+ M1 macrophages and CD8 T cells in the adipose
tissue of HFD-fed mice compared to lean counterparts (Fig. 4).
However, the number of M1 macrophages and CD8 T cells in the
adipose tissue were similar in WT and klrk-/- mice. We also
confirmed that there was no difference in CD8 T cell infiltration
after 3 weeks of HFD, when NKG2D ligand expression was
highest (data not shown). These results indicate that NKG2D does
not affect CD8 T cell recruitment to the adipose tissue during
obesity.
Obesity-induced adipose tissue inflammation in fat-
specific Rae-1e transgenic mice. In order to confirm these
results, we generated a transgenic mice specifically over-expressing
Rae-1e in the adipose tissue (AdpnCre+ Rae+) by crossing
adiponectin-Cre mice [41] with PCCALL-Rae1e mice [35].
Real-time qPCR was used to confirm Rae-1e over-expression in
the adipose tissue (Fig. 5A). Rae-1 mRNA levels were not altered
in liver and muscle (data not shown), indicating specific
overexpression of Rae-1e in the adipose tissue. It is known that
NKG2D expression in NK cells and T cells is down-regulated in
transgenic mice constitutively overexpressing NKG2D ligands
[43,44]. Indeed, we observed loss of NKG2D expression in NK
cells isolated from the adipose tissue, but not spleen or blood, again
confirming fat-specific overexpression of Rae-1 in the Adpn+ Rae+
mice (Fig. 5B).
To examine the early events of obesity-induced immune cell
infiltration, these transgenic mice (AdpnCre+ Rae+) were placed
on a high-fat diet for 5 weeks, along with age-matched control
mice lacking the transgene (AdpnCre+ Rae2). At the end of 5
weeks, the SVF from the adipose tissue were analyzed by flow
cytometry. Adipose tissue from obese mice contained approxi-
NKG2D in Obesity-Induced Adipose Tissue Inflammation
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mately twice the number of M1 macrophages and CD8 T cells
compared to lean mice (Fig. 5C). However, the number of CD8 T
cells and M1 macrophages in the adipose tissue was not altered by
fat-specific overexpression of Rae-1e. These results are consistent
with the observations made in klrk-/- mice and confirm that
NKG2D is not involved in the recruitment of CD8 T cells to the
adipose tissue during obesity.
The klrk-/- mice and AdpnCre+ Rae+ mice used in the previous
experiments were housed in specific pathogen-free conditions, and
therefore, the number of circulating CTLs is minimal. In mice,
NKG2D is expressed in activated CTLs, but not in naı¨ve CD8 T
Figure 2. NKG2D ligands are increased in the adipose tissue of obese mice. Expression of NKG2D ligands in the epididymal adipose tissue
from (A) DIO-mice (8 weeks on HFD) and (C) ob/ob mice was determined by quantitative PCR. mRNA levels of CD68, TNF-a, MCP-1, adiponectin, and
adipsin were measured in (B) DIO-mice and (D) ob/ob mice for control. (E) The epididymal adipose tissue of DIO-mice (6 weeks on HFD) was
fractionated into the stromal vascular fraction and adipocytes and analyzed by quantitative PCR for expression of NKG2D ligands. (F) Adipocytes were
obtained from the epipdidymal adipose tissue of DIO-mice at different time points after starting high-fat diet. The adipocytes were then analyzed by
quantitative PCR for expression of NKG2D ligands. The results were normalized to (A–D) HPRT or (E, F) b-actin levels and are shown as fold-increase
over (A–D, F) lean control mice or (E) stromal vascular fraction. The data represent mean6 SD of 3 independent experiments. * p,0.05, ** p,0.01 vs.
(A–D, F) lean control mice or (E) stromal vascular fraction.
doi:10.1371/journal.pone.0110108.g002
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cells. We therefore speculated that the lack of a phenotype could
be due to low numbers of circulating CTLs. In addition, it was
possible that the constitutive overexpression of Rae-1e was down-
regulating NKG2D expression in circulating T cells. To circum-
vent these issues, and to directly test whether up-regulation of
NKG2D ligands can induce recruitment and accumulation of
cytotoxic CD8 T cells in the adipose tissue, we intravenously
injected CFSE-labeled CTLs into control and AdpnCre+ Rae+
mice. 24 hours after injection, we measured the number of CFSE+
CTLs recruited to the spleen and adipose tissue (Fig. 6). Similar
numbers of CFSE+ CTLs were detected in the spleen of AdpnCre+
Rae2 and AdpnCre+ Rae+ mice, indicating that equal number of
CTLs was successfully transferred to each mouse. In the adipose
tissue, the overexpression of Rae-1e did not result in increased
recruitment of CTLs. These results demonstrate that, in contrast
to pancreatic islets, NKG2D-NKG2D ligand interaction is not
sufficient to drive accumulation of NKG2D-expressing CTLs in
the adipose tissue.
Figure 3. Susceptibility to obesity-induced insulin resistance is not altered in klrk-/- mice. (A) Body weight of WT and klrk-/- mice placed
on normal diet or high-fat diet for 18 weeks. (B) Fasting blood glucose levels measured after 0, 6, 12, and 18 weeks on high-fat diet. (C) Glucose
tolerance test and (D) insulin tolerance test performed after 0, 6, 12, and 18 weeks on high-fat diet. The numbers of mice used for each experiments
were at least 10 for WT normal diet, at least 9 for WT high-fat diet, at least 16 for klrk-/- normal diet, and at least 18 for klrk-/- high-fat diet.
doi:10.1371/journal.pone.0110108.g003
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Discussion
In this study, we tested a model of antigen-independent
recruitment of CD8+ T cells to the adipose tissue during obesity
via NKG2D-NKG2D ligand engagement. Results from our
experiments suggest that interaction between the immunoreceptor
NKG2D and its cognate ligands is not critically involved in the
development of adipose tissue inflammation during diet-induced
obesity. Neither deletion of NKG2D nor fat-specific overexpres-
sion of an NKG2D ligand had significant effects on insulin
sensitivity or infiltration of immune cells to the adipose tissue in the
setting of a high-fat diet.
The non-development of phenotype does not seem to be due to
strain-specificity of the mice used in our experiments. The
composition of immune cells is known to vary among different
strains of mice [45]. In addition, the immune system is
compromised in certain genetic obese mice models, such as the
ob/ob mice or the db/db mice, because leptin is required for
immune cell homeostasis, especially T cells [46]. In order to avoid
such variables, we chose to utilize the diet-induced obese (DIO)-
mouse model using C57BL/6 mice. The C57BL/6 strain is the
predominant strain used to study nutrient-dependent metabolic
disorders in the literature and was the strain used to demonstrate
the involvement of various immune cells in obesity-induced
inflammation.
The NKG2D-deficient mice display a NK cell hyperprolifera-
tion phenotype [40], which could be a confounding factor in the
case that NK cells are also involved in adipose tissue inflammation.
However, as of date, NK cells have not been clearly implicated in
obesity-induced insulin resistance. There have been conflicting
reports of changes in the number of NK cells in the adipose tissue
during obesity. In our experiments, we did not observe a clear
reproducible pattern of NK cell recruitment.
Similar to the NKG2D-deficient mice, we did not observe any
difference in immune cell infiltration in the fat-specific Rae-1e
mice. We could not directly determine the protein level of Rae-1e
in the adipocytes of the fat-specific Rae-1e mice due to the lack of
antibodies suitable for immunohistochemistry or Western blots
and the technical difficulties in performing flow cytometry with
adipocytes. However, we did observe a nearly complete down-
regulation of NKG2D specifically in NK cells isolated from the
adipose tissue, but not in cells isolated from spleen or blood. It is
well known that engagement of Rae1e by NKG2D results in
NKG2D down-regulation [37,43,47]. Therefore, these results
show that the level of transgene expression was sufficient to
completely quench NKG2D expression on NK cells in the adipose
tissue, suggesting that Rae-1e is being expressed at biologically-
relevant levels.
Although we observed induction of both Rae-1 and Mult-1 in
obese mice, only Rae-1 was expressed predominantly in fat cells. It
should be noted that adipocyte fractions isolated from adipose
tissue of obese mice are often contaminated with lipid-laden
immune cells, which could have affected the outcome of the
NKG2D ligand expression analyses. Nonetheless, we speculated
that overexpressing Rae-1e in the adipose tissue would closely
resemble the expression pattern of NKG2D ligands during obesity.
It is possible that overexpressing Mult-1 instead could have yielded
different results.
It has been shown that circulating levels of CD8+ T cells in male
C57BL/6 mice are relatively low compared to other mouse
strains. In addition, NKG2D is only expressed in activated CD8+
T cells, the number of which may not be sufficient in mice raised
in a SPF facility. In order to circumvent these issues, we adoptively
transferred activated CTLs into the fat-specific Rae-1e transgenic
mice. Contrary to our expectations, overexpression of Rae-1e in
adipocytes did not lead to accumulation of CTLs in the adipose
tissue. This is in contrast to previous results from similar
experiments performed in the pancreatic islets [35]. This may be
due to differences in the architecture of the vasculature between
the pancreas and the adipose tissue, which could affect how
surface proteins are detected by lymphocytes in circulation.
Despite the lack of evidence for the involvement of NKG2D in
obesity-induced inflammation and insulin resistance, it is still
interesting that NKG2D ligands are up-regulated in the adipose
tissue in response to a high fat diet. In fact, the human NKG2D
ligands MICA and MICB have been shown to be induced in the
liver of obese patients [48]. In addition, NKG2D ligands are
induced in the aorta of ApoE-/- mice fed a western diet and are
involved in atherosclerotic plaque formation [38]. The nature of
Figure 4. Immune cell infiltration of adipose tissue during obesity is not altered in klrk-/- mice. The stromal vascular fraction was isolated
from the epididymal adipose tissue of DIO and lean mice after 18 weeks on the diet regimen. The cells were stained with antibodies to identify M1
macrophages (F4/80+, CD11c+), M2 macrophages (F4/80+, CD11c-), CD4 T cells (CD3e+, CD4+), CD8 T cells (CD3e+, CD8+), and NK cells (CD3e-, NK1.1+)
and analyzed by flow cytometry. The cells were gated on 7AAD2, CD45+ populations. The data represent mean 6 SD of 3 independent experiments.
doi:10.1371/journal.pone.0110108.g004
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the response of the immune system to NKG2D ligand induction
necessitates a tight regulation of its expression. Previous studies
have shown that various ‘cell stress’ conditions, including DNA
damage and viral infection, can induce NKG2D ligand expression.
However, it seems that such cues are not sufficient to up-regulate
NKG2D ligands in all cell types. It is more likely that different
signals trigger the expression of the multiple NKG2D ligands in
different cell types. Indeed, insulin and TNF-a were able to
significantly increase transcript levels of Rae-1 and Mult-1, but not
H60b, in differentiated 3T3-L1 adipocytes. Notably, high-fat diet
resulted in the up-regulation of the same subgroup of NKG2D
ligands, namely Rae-1 and Mult-1. Therefore, it is tempting to
speculate that these signals are also responsible for the induction of
NKG2D ligands in the adipose tissue in vivo given that insulin and
TNF-a levels are known to be elevated in obesity.
Interestingly, multiple NKG2D ligands were expressed in
undifferentiated 3T3-L1 cells and the expression levels decreased
after differentiation (data not shown). This could be attributed to
the cease of proliferation that occurs when 3T3-L1 cells
differentiate. It was recently demonstrated that Rae-1 expression
is regulated by the transcription factor E2F, which is associated
with cell cycle. On the other hand, it is also possible that NKG2D
ligand expression is actively repressed by the differentiation
process. Identification of such factors would shed light on how
the strict regulation of NKG2D ligands is achieved in various cell
types.
Figure 5. Immune cell infiltration of adipose tissue during obesity is not altered in AdpnCre+ Rae+ mice. (A) The epididymal adipose
tissue from AdpnCre+ Rae+ and control mice were analyzed by quantitative PCR to determine Rae-1 expression. The results were normalized to b-
actin levels and are shown as fold-increase over AdpnCre2 Rae2 mice. (B) Splenocytes, peripheral blood mononuclear cells (PBMC), and stromal
vascular fractions isolated from the epididymal adipose tissue of AdpnCre2 Rae+ and AdpnCre+ Rae+ mice were stained with NKG2D antibodies and
analyzed by flow cytometry. Cells were gated on 7AAD2, CD45+, CD3e2, NK1.1+ populations. (C) The stromal vascular fraction isolated from the
epididymal adipose tissue of AdpnCre+ Rae2 and AdpnCre+ Rae+ mice after 5 weeks on the diet regimen were stained with antibodies and analyzed
by flow cytometry. The cells were gated on 7AAD2, CD45+ populations. The data represent mean 6 SD of 3 independent experiments.
doi:10.1371/journal.pone.0110108.g005
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The biological significance of NKG2D ligand induction in the
adipose tissue during obesity is unclear. Adipocytes in the adipose
tissue of HFD-fed mice are subjected to various cell stress
conditions due to increased metabolic loads, hypoxic conditions,
and proinflammatory environment. Hence, the most obvious
explanation would be that NKG2D ligands are being expressed by
damaged adipocytes. It should be noted that the different types of
NKG2D ligands do not seem to respond in the same manner.
Only Rae-1 and Mult-1 were induced by the introduction of the
high-fat diet while H60b levels remained the same. Furthermore,
Rae-1 was predominantly found in adipocytes whereas Mult-1
expression levels were similar in adipocytes and stromal vascular
cells. How these differences affect adipose tissue homeostasis and/
or pathology during obesity remain to be determined.
In summary, our results rule out the interaction between
NKG2D and its ligands as a possible mechanism of CD8+ T cell
recruitment to the adipose tissue during obesity. Our findings
regarding the induction of NKG2D ligands in the adipose tissue
during obesity provide a new model to investigate the mechanisms
involved in the regulation of NKG2D ligand expression.
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